Comparison of the clinical features of pituitary incidentalomas and symptomatic pituitary tumors

Clinical features and therapies of pituitary incidentalomas - Study of pituitary incidentalomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040299

Enrollment

200

Registered

2020-05-05

Start date

2019-09-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pituitary tumors

Exclusion criteria

Exclusion criteria: Unknown medical history, no baseline hormone data, Rathke's cleft cyst, meningioma, metastatic tumor, lymphocytic adenohypophysis, IgG4-related hypophysis, and uncertain pathology.

Design outcomes

Primary

Measure	Time frame
Pituitary hormone deficiency	—

Secondary

Measure	Time frame
Age,Sex,BMI, tumor characteristics,postoperative complications	—

Countries

Japan

Contacts

Public ContactIzumi Fukuda

Graduate School of Medicine, Nippon Medical School Department of Endocrinology, Diabetes and Metabolism

i-fukuda@nms.ac.jp03-5814-6864

Outcome results